Biomarker
Sep. 15, 2010
The in vitro diagnostics software Ariol on the Leica DM6000 B Research Microscope creates a perfect pathology workstation for the assessment of clinical brightfield and fluorescent biomarkers. The system integrates seamlessly into the pathologist's workflow with the means to digitize whole slides or regions of interest.
moreAug. 03, 2010
PerkinElmer announced that it has acquired VisEn Medical an in vivo molecular imaging technology company based in Bedford, Massachusetts. The acquisition enables PerkinElmer to enhance its cellular imaging business, by expanding the Company's technologies and capabilities downstream into preclinical research undertaken in academic institutes and pharmaceutical companies. VisEn's proprietary fluorescence molecular imaging systems and reagents are currently used in applications involving research into cancer, inflammation, cardiovascular, skeletal and pulmonary diseases.
moreMar. 19, 2010
Promega and TOP (Transgenic Operative Products) have combined their industry technologies to provide the sensitive tools for monitoring apoptosis in live mammals, an important biomarker in cancer studies. Under the agreement, the two companies are promoting the VivoGlo Caspase 3/7 Substrate for use with transgenic repTOPTM reporter mice. The tools allow the direct visualization and quantification of apoptosis non-invasively in live mice.
moreNov. 04, 2009
Normal and diseased tissues are complex mixtures of different cell populations. A better understanding of protein expression changes that occur during 
diseases needs sensitive and specific technologies for each of these cell types. Mass spectrometry based tissue imaging (MALDI-MSI) is a newly developed technique, allowing the visualization of proteins, peptides, lipids and small molecules directly on thin sections cut from fresh frozen or fixed paraffin embedded tissues.
more